Epigenetic (de)regulation of adult hippocampal neurogenesis : implications for depression by Pinheiro, António Mateus et al.
REVIEW Open Access
Epigenetic (de)regulation of adult hippocampal
neurogenesis: implications for depression
António Mateus-Pinheiro1,2, Luísa Pinto1,2 and Nuno Sousa1,2*
Abstract
Adult neurogenesis represents a dynamic level of modulation upon the neuroplastic properties of the mature
nervous system, that is essential to the homeostatic brain function. The adult neurogenic process comprises several
sequential steps, all of which subjected to an assortment of cell-intrinsic and neurogenic-niche complex regulatory
mechanisms. Among these, epigenetic regulation is now emerging as a crucial regulator of several neurogenesis
steps. In particular, the active regulation of hippocampal neurogenesis and its repercussions in global hippocampal
function are of special interest for the biomedical field, since imbalances at this level have been strongly related to
the precipitation of several neuropsychyatric disorders, such as depression. Indeed, growing evidence supports that
the detrimental effects on adult hippocampal neurogenesis, that have been associated with depression, might be
epigenetically-mediated. Therefore, understanding the epigenetic regulation of the neurogenic process may
provide a link between neurogenesis imbalances and the deterioration of the behavioural and cognitive domains
frequently affected in depression, thus contributing to unravel the complex pathophysiology of this disorder.
Here, we outline some of the major epigenetic mechanisms contributing to the regulation of hippocampal
neurogenesis and discuss several lines of evidence supporting their involvement on the development of
imbalances in the neurogenic process, often correlated to behavioural and cognitive deficits commonly observed
in major depressive disorder.
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Adult neurogenesis: the neurogenic process and
its epigenetic regulation
Neurogenesis in the adult brain
The beauty of research is that it ultimately defeats all
established dogmas, even though some take very long to
fall. Cajal’s decree concerning the immutability of the cen-
tral nervous system (CNS) has been reviewed and updated
during the last decades, due to mounting evidence that
substantiates the regenerative potential and plasticity of
the CNS. Despite the initial reluctance manifested towards
the first reports of post-natal neurogenesis, it is now well
established that neurogenesis, a process that comprises the
generation, differentiation and integration of new neurons
in the preexisting brain neuronal networks, occurs in the
adult brain, prevailing throughout life in specific brain
areas, where neurons are persistently generated [1,2]. Such
spatially defined brain regions where neurogenesis occurs
display a permissive microenvironment for the mainte-
nance and differentiation of neural stem cells and to their
proliferation. Currently, two neurogenic brain regions are
broadly recognized in the mammalian adult brain: the sub-
granular zone (SGZ) of the hippocampal dentate gyrus
(DG) and the subependymal zone (SEZ) in the lateral
ventricles.
In the hippocampal formation, the precursor cell popu-
lation resides throughout the SGZ, with specific gradients
[3]. After being generated in the SGZ, newly-born cells
become committed to a neuronal lineage and migrate into
the granule cell layer (GCL), where they mature to become
excitatory glutamatergic granule neurons [4,5]. In the SEZ
the precursor cells are mostly found in the anterior seg-
ment of the walls of the lateral ventricles. Here, newly-
born precursor cells generate neuroblasts that will migrate
along the rostral migratory stream (RMS), reaching the
olfactory bulb (OB), where they fully differentiate mostly
into granule inhibitory interneurons [6,7]. In addition to
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these two consensually accepted neurogenic regions, some
authors have presented evidence that neurogenesis occurs
in other brain areas, including the striatum [8], the cortex
[9,10], the amygdala [11] and the hypothalamus [12,13];
however, as these results are still disputable [14,15],
further studies are needed in order to elucidate if other
neurogenic niches are indeed present in the adult brain.
Although it is now indisputably accepted that neuro-
genesis occurs in the adult brain, its functional relevance
remains to be fully established. While it is clear that this
phenomenon is confined to very discrete brain regions,
the generation of new neurons in the post-natal period
constitutes a new dimension of plasticity, with both
direct and indirect impact on neuronal remodelling and
repair, that is now regarded by the biomedical field as a
promising therapeutical target in several neuropathologi-
cal contexts. Notably, abnormal alterations in the hippo-
campal neurogenesis process have been implicated in an
assortment of neuropsychiatric disorders [16-18]. Several
research works, seeking to unveil the biological mechan-
isms underlying these disorders, became comprehensive
studies about the hippocampal neurogenic process. Quite
surprisingly, the functional relevance of adult neurogen-
esis in the SEZ has not yet been directly related to any
specific neuropathological condition.
A brief overview on adult hippocampal neurogenesis
Integration of newly-born hippocampal neurons into pre-
established neural networks seems to be achieved
through highly regulated sequential steps: proliferation of
neural stem cells, generation of amplifying progenitors,
cell migration and, finally, maturation in the definitive
destination with axon and dendrites formation and estab-
lishment of new synapses with preexisting surrounding
cells [19-21] (Figure 1). This process of post-natal neuro-
genesis largely recapitulates the embryonic one, with the
major difference that new neurons have to undergo these
steps in an already mature microenvironment, having to
integrate preexisting neural circuits.
The adult hippocampus SGZ contains an heterogeneous
precursor cell population, distinctly identifiable through a
particular set of molecules that each cell type expresses.
The quiescent neural progenitors (QNPs) are believed to
be the multipotent stem cells residing on the hippocampus
[5,22]; they are also known as neural stem cells (NSCs) or,
according to an alternative nomenclature, type-1 progeni-
tor cells. Having both morphological and antigenic glial
properties [23,24], they can be further distinguishable into
two classes according to their spatial orientation: horizon-
tal astrocytes (hA) and radial astrocytes (rA). These cells
divide asymmetrically giving rise to daughter cells known
as transiently amplifying neural progenitors (ANPs; also
generally designated as type-2 progenitor cells). This phase
of the neurogenic process comprises the emergence of the
first indications of neuronal or non-neuronal lineage com-
mitment [21], being for such reason, a decisive checkpoint
in the determination of neural progenitors cell-fate.
Anomalous alterations in this phase of the neurogenic
process often result in long-term neuropathological traits
[25]. Studies have showed that ANPs are highly mitotic
[1,25], dividing symmetrically and giving rise to neuro-
blasts (NBs; also named type-3 progenitor cells). Neuro-
blasts are intermediate precursors in the generation of
new granule neurons, expressing the microtubule asso-
ciated protein doublecortin (DCX) that will be crucial for
further maturation and migration [19,26]. Once the new-
born cell becomes a neuroblast, it exits the proliferation
cycle, and migrates towards its final destination in the
GCL. Here, the newly-born cells will fully maturate, elon-
gating their axons and establishing new functional connec-
tions, eventually becoming a mature granule neuron. The
time window that takes to a newborn cell to be fully
mature and integrated in the preexisting neural network is
typically referred to be approximately five weeks [27,28];
however, some authors claim that the entire period of
adult neurogenesis can take as much as 7 weeks [29,30], as
this is the time required by the new neurons to become
electrophysiologically indistinguishable from the remain-
ing neuronal population.
Importantly, neurogenesis is a fine tuned process,
rather than a mass phenomenon, during which most
newborn cells are eliminated [31,32]. The mechanisms
that regulate this neurogenic process are still to be fully
understood, but recently, several studies proposed a com-
plex epigenetic orchestration of adult hippocampal
neurogenesis.
Epigenetic orchestration of adult neurogenesis
Functional and structural chromatin properties are actively
regulated in hippocampal NSCs. In fact, and despite being
a relatively recent concept in the neuroscience field, the
importance of epigenetics on the fine regulation of prolif-
eration, fate specification and differentiation of NSCs is
now becoming to be recognised as fundamental for the
balanced production of new neuronal and glial cells, neces-
sary for the homeostatic brain function. Therefore, it
becomes gradually evident that both extracellular signalling
and intracellular epigenetically regulated gene expression
programs are dynamically involved in adult neurogenesis.
Notably, the intracellular epigenetic program regulating
adult neurogenesis is proposed to be quite similar to the
epigenetic regulation occurring during development, but is
also determined by a myriad of new extrinsic physiological
and environmental stimuli [33], that allow the alignment of
neurogenesis with the external requests. Even though there
is still much to be known, a global picture regarding the
epigenetic orchestration of adult neurogenesis commences
to emerge (Figure 2).
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Epigenetic regulation is implicated in the first stages of
adult neurogenesis, by promoting the maintenance of the
self-renewal potential of adult NSCs. Molofsky and col-
leagues [34] highlighted the importance of the trithorax
(trxG) and the functionally antagonistic polycomb (PcG)
groups of proteins on such regulatory function. The trxG
and PcG proteins are chromatin modifier complexes that
will, respectively, activate or silence the targeted loci,
maintaining such transcriptional state for several cell
divisions [35-37]. In particular, the PcG zinc-finger pro-
tein Bmi1 has been identified as an important epigenetic
regulator, promoting H3K27 methylation and repressing
the expression of the cyclin-dependent kinase inhibitor
gene p16 (Ink4a); as a consequence the proliferative rate
of adult NSCs is maintained [38,39]. In addition, Methyl-
CpG binding protein 1 (Mbd1) also appears to be
involved in adult NSCs self-renewal in the SGZ. So far,
this is the only Mbd protein reported to be specifically
involved in hippocampal neurogenesis; Mbd1 deficient
mice, although without noticeable developmental deficits,
have reduced NSCs proliferation that correlate with cog-
nitive impairments in spatial memory [40]. This protein
binds to the promoter region of the gene encoding the
mitogen Fibroblast Growth Factor 2 (Fgf2), controlling
its expression on adult NSCs of the SGZ. Regulation of
the expression of Fgf2 provides the precise control of the
timing for the cell to exit the proliferation cycle and to
initiate its differentiation [41]. In addition, the MYST
family histone acetyltransferase Querkopf (Qkf or
Myst4), whose expression was recently described in the
adult hippocampus [42], also appears to be involved in
the regulation of adult NSCs self-renewal, as NSCs iso-
lated from Qkf mutant mice exhibited a reduced self-
renewal capacity [43]. It is important to mention that
these epigenetic regulators involved in the adult NSCs
maintenance, operate together with several other epige-
netic protein regulators such as DNA methyltransferases
(DNMTs), histone acetyltransferases (HATs), histone
deacetylases (HDACs), and histone methyltransferases
(HMTs), that will actively participate in further regula-
tory steps of the neurogenic process.
When exiting the mitotic phase, neural progenitor cells
will eventually become committed to a specific neural cell
lineage and start to differentiatiate. Neuronal or glial line-
age commitment of NSCs involves a temporal-defined
mutual regulation of several gene batteries. Commitment
to a neuronal cell-fate, for instance, involves the repression
of gliogenic genes; the alternative scenario of glial differen-
tiation, requires the inhibition of genes responsible for
neuronal specification. This is achieved through transcrip-
tional and epigenetic regulation, that will integrate also the
cell response to the extrinsic environment. In this context,
HDACs and HATs are believed to exert an important role
in the transduction of physiological signals to the stem cell
genome, activating or repressing specific gene programs in
NSCs. In general, HDACs catalyze the deacetylation of
nucleossomes, that become highly condensed, obstructing
the access of transcriptional activation factors to their
binding sites and, therefore, resulting in transcriptional
repression. In contrast, HATs catalyze the opposite
Figure 1 Neurogenesis in the dentate gyrus (DG) of the adult rodent hippocampus. The adult neurogenic process encompasses several
highly regulated sequential steps. The process begins with the asymmetrical division of neural stem cells (NSCs), also named quiescent neural
progenitors (QNPs or type 1 progenitors), giving rise to amplifying neural progenitors (ANPs or type 2 progenitors). ANPs start to exhibit the first
signs of cell-lineage commitment and eventually exit the mitotic phase to become neuroblasts (type 3 progenitors). The neuroblasts will then
differentiate and migrate towards its final destination where they will fully maturate into granular neurons and establish synapses within pre-
existing circuits. Each cell stage can be distinctively identifiable by cell markers, some of which are indicated. It is currently assumed that the
entire process of adult neurogenesis takes around 4 to 5 weeks. (GFAP - Glial fibrillary acidic protein; DCX - Doublecortin; PSA-NCAM -
Polysialylated-neural cell adhesion molecule: NeuN - Neuronal Nuclei)
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reaction, resulting in global nucleossomal relaxation and,
consequently, in increased transcriptional activity [44]. A
hint for the importance of these epigenetic modifiers on
the neurogenic process, was provided when administrating
HDACs inhibitors (HDACis), such as trichostatin A or
valproic acid (VPA) on rats. Using such experimental
approach, it was shown that HDACis promote neuronal
differentiation of adult neural progenitor cells [45]. In
addition, at this differentiation stage other proteins, such
as trxG proteins, exert their modulatory actions which will
ultimately determine cell-fate specification. One interest-
ing example is provided by the trxG family member, Mll1
(mixed-lineage leukaemia 1), which is a H3K4 HMT.
Mll1-deficient NSCs retain the capacity to proliferate and
fully differentiate into glial lineages, but neuronal differen-
tiation becomes severely compromised. Therefore, Mll1
seems to be required to mediate the transition from a
silenced to an active transcriptional state in key loci of
postnatal neural precursors necessary for the induction of
neurogenesis [46].
Although several other epigenetic regulatory players in
cell-fate specification have been identified, it becomes dif-
ficult to consider a unifying model through which all
epigenetic regulatory actions are coordinated. Neverthe-
less, a promising candidate for orchestrating these epige-
netic events is the DNA binding protein REST (Repressor
Element 1 Silencing Transcriprition Factor). REST was
first described in 1995, as a repressor of neuronal genes
containing a 23 bp conserved sequence, known as RE1
(Repressor Element 1, also named neuron-restrictive silen-
cing factor, or NRSF) [47,48]. This transcription factor
coordinates the action of several epigenetic complexes
that are required when switching from the undifferentiated
stem cell state through the stages of neuronal or glial cell-
fate specification [49-51]. After binding to DNA, REST
orderly recruits several DNMTs, HMTs, HATs, HDACs,
MBDs, co-regulators (CoREST) and cell-cycle proteins,
promoting shifts in the overall transcriptional state of spe-
cific gene batteries in a cellular context-sensitive manner
[49,52]. The recruited epigenetic modulatory proteins,
together with specific non-coding RNAs, interact with
REST, allowing the precise control of the cellular events
that lead to neural progenitors subtype specification
[53,54].
Epigenetic regulation is now known to be also impli-
cated in the final maturation of newborn neurons; at this
Figure 2 Epigenetic regulators of the adult hippocampal neurogenic process. The adult hippocampal neurogenic process is subjected to a
complex epigenetic regulation, with important functional implications. Different types of epigenetic regulators have been identified, including
PcG and TrxG protein complexes, MBDI, the REST/CoREST complex, MeCP2, HDACs, HATs and DNMTs, specifically involved in the fine tunning of
the proliferation and specification of neural progenitors, as in the differentiation and maturation of the newborn neurons. Epigenetic regulators,
such as the PcG protein Bmi1 and the methyl-binding protein MBD1 are involved in the regulation of the initial steps of neurogenesis,
participating in NSCs self-renewal and maintenance. Later on the neurogenic process, the transcriptional activation of specific gene batteries by
TrxG proteins like Mll1, together with the action of chromatin remodeling complexes such as the REST/CoREST complex and its molecular
partners will allow the progenitor cells to exit the proliferation cycle and become committed to a neural cell lineage. Finally, the action of
regulators such as MeCP2, will contribute to post-mitotic neuronal differentiation and maturation. Some epigenetic regulators, such as HDACs,
HATs and DNMTs are involved in several regulatory checkpoints of the adult neurogenic process, integrating several protein regulatory
complexes involved in the transcriptional activation of pro-neurogenic genes.
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stage it has an important role in promoting the integration
of newly-born neurons into the preexisting neural net-
works. HDACs and HATs appear to be once again deci-
sive for neuronal maturation and early synaptogenesis
[55,56]. Using mice deficient on HDAC1 or HDAC2, it
was shown that a decreased activity of both enzymes in
immature hippocampal neurons triggers excitatory
synapse maturation; however, exclusive inhibition of
HDAC2 triggers the opposite effect and promotes reduced
excitatory synaptic activity [55,57]. Another important epi-
genetic regulator in the SGZ granule neurons is the
methyl-CpG-binding protein 2 (MeCP2). Interestingly, in
postmitotic SGZ neurons, the expression of brain-derived
neutrophic factor (BDNF), a neurotrophin actively
involved in dendritic growth and spine maturation, is asso-
ciated to reduced DNA methylation and to the release of a
chromatin repressive complex comprising MeCP2, in
which these cells are highly enriched [58,59]. Furthermore,
it has been demonstrated, using knockout mice, that
MeCP2 deficiency causes severe deficits in the maturation
of newborn neurons in the SGZ, including delayed differ-
entiation and reduced dendritic spine density [60]. In addi-
tion, BDNF expression (as well as FGF) can be controlled
by other epigenetic regulators such as the DNA-damage
inducible protein 45b (Gadd45). This protein is an activ-
ity-induced immediate early gene, and its transcription is
sensitive to various stimuli that increase neurogenesis by
DNA demethylation in mature neurons of neurogenic
niches, contributing to the paracrine secretion of neuro-
trophic factors (BDNF and FGF) that control key pro-
cesses in adult neurogenesis, including neuronal and
dendritic maturation [61,62].
Finally, it is important to note that this epigenetic regu-
lation is not only mediated through cell-intrinsic mechan-
isms, and that epigenetic mediators are likely stable
transducers of extracellular signals (e.g. neuronal activity-
dependent or from adjacent glial or endothelial cells) into
the regulation of all phases of neurogenesis. The paracrine
action of MeCP2 and Gadd45b are amongst the best
known examples of this integration of intrinsic and extrin-
sic signals relevant for neurogenesis regulation [63-65].
Noticeable, these epigenetic regulators exert a complex
orchestration of neurogenesis and, therefore, it is plausible
that a deregulation of this epigenetic regulatory process is
implicated in the neurogenic impairments observed in sev-
eral neuropsychiatric disorders.
Role of epigenetic (de)regulation in the
ethiopathogenesis of depression: impacts on
neurogenesis
Adult hippocampal neurogenesis on the pathophysiology
of depression
Adult hippocampal neurogenesis represents an important,
and formerly underestimated, form of neuroplasticity,
namely in the hippocampal formation, a brain structure
involved in several neuropsychyatric disorders [17,18,66].
Indeed, there is now mounting evidence for the implica-
tion of adult hippocampal neurogenesis in the pathophy-
siology of several neuropsychiatric disorders, a topic
extensively reviewed elsewhere [16,19,67]. Perhaps one of
the most striking findings in this scientific context was the
involvement of adult neurogenesis imbalances in the
pathophysiology of major depressive disorder (MDD), as
in the action of several antidepressant drugs, thus leading
to the substantiation of the so called “neurogenic hypoth-
esis of depression” [68,69]. In fact, several studies have
linked reduced neurogenesis to depressive-behaviour and
even to the action of several antidepressant drugs [70-73].
Indeed, during the last decade it became obvious the
scientific insufficiency of the previously predominant neu-
rochemical-based hypothesis to explain the precipitation
of depression, with several authors putting forward alter-
native underlying mechanisms for the ethiopathogenesis
of this disorder [74-76].
Impaired neuronal plasticity is increasingly viewed as
central in the ethiopathogenesis of depression. In fact, dur-
ing the last two decades a significant number of studies in
this field revealed cell loss and neuronal atrophy, particu-
larly in brain loci relevant for emotional behaviour control.
Several mechanisms were proposed to be responsible for
this neuronal atrophy, namely glucocorticoid and gluta-
mate toxicity for both glia and neurons [77], decreased
neurotrophic factors expression [78,79], and, more inter-
estingly, decreased neuroplasticity, including dendritic
atrophy in the hippocampus in some executive-function
brain centres as the prefrontal cortex (PFC) (Bessa et al.,
2009b) in animal models for depression. However the
most robust link between impaired neuroplasticity and
MDD derives from a large number of studies reporting
impaired neurogenesis in subjects displaying depressive-
like symprtoms [80-82]. Further support to the association
of hippocampal neurogenic control and depression,
derives from the analysis of the effects of some antidepres-
sants (ADs) in the adult neurogenic process. Counteract-
ing the adverse effects of some of the inducing factors of
MDD, ADs bolster neurogenesis in the mammalian hippo-
campal DG. This pharmacological enhancement of neuro-
genesis was reported with different classes of ADs,
including selective serotonin reuptake inhibitors (SSRIs),
monoamine oxidase inhibitors (MAOIs), tricyclic agents
and even with putative ADs [70-73,79,83]. Consistent with
the results obtained in animal models of depression, ADs
also exert this pro-neurogenic effect in non-human pri-
mates and humans [84,85].
Lastly, a third link between MDD and hippocampal
neurogenesis, is reflected in the functional importance of
the adult neurogenic process in some of the behavioural
domains commonly affected in depressive patients, such
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as mood, anxiety and cognition [86-89]. However, the
initial proposals claiming that the neurogenic modulatory
effects of ADs were responsible for all the behavioural
improvements observed after chronic treatment with
these drugs is an oversimplification as demonstrated by
several studies [70,71,90-93]. In fact, we have demon-
strated that the short-term mood-improving actions of
antidepressants depended on neuronal remodelling,
rather than on neurogenesis [70]. This is not surprising
when considering that the pro-neurogenic effects
mediated by ADs would not be of neurobiological signifi-
cance at short-term, since a newborn neuron takes
approximately a 5 weeks period to be fully differentiated
and integrated in the neuronal circuitry of the adult DG.
However, as the majority of studies focus on short-term
analysis, one cannot rule out the possibility that the func-
tional contribution of AD-induced neurogenesis will only
take place at the long-term. In fact, preliminary data
from our lab suggests that despite triggering an immedi-
ate pro-neurogenic response, the neurobiological impor-
tance of this effect of ADs becomes only significant later
on the course of the disease, since the artificial suppres-
sion of neurogenesis by the anti-mitotic agent methyla-
zoxymethanol (MAM) significantly compromises
behavioural and cognitive long-term recovery, an effect
that can be counteracted by ADs treatment (unpublished
data).
Epigenetic (de)regulation of adult neurogenesis as a
possible precipitator of depression
During the last decade, compelling evidence has emerged
for the participation of epigenetic regulatory mechanisms
in adult hippocampal neurogenesis. Therefore, it appears
reasonable to conceive the hypothesis that dysfunction in
epigenetic regulatory mechanisms might mediate the
neurogenic imbalances responsible for some neuropsy-
chiatric conditions, such as depression. Although this
idea is still controversial, several lines of research suggest
that different epigenetic regulatory mechanisms of adult
neurogenesis are affected in animal models of depression
(Figure 3).
A paradigmatic case supporting this hypothesis is the
already mentioned methyl-CpG-binding protein MBD1.
In fact, an elucidative work conducted by Allan and
colleagues [94], showed that Mbd1-deficient mice,
besides having decreased NSCs proliferation, as already
described by Zhao et al., also exhibit significant deficits
in several behavioural dimensions relevant for depres-
sion: increased anxious phenotype, detected in both
elevated plus maze and light-dark preference tests;
behavioural despair, observed in the forced swimming
test; and cognitive deficits manifested during the
execution of Morris water maze spatial learning tasks
[94].
Another example derives from studies focused on
MRG15, an active component of HDACs complexes, such
as HDAC2 [95,96]. Indeed, Mrg15-deficient mice present
significant deficits in proliferation of neural progenitors
and in their subsequent differentiation [97]. Interestingly,
HDAC2 has been identified as a negative regulator of
memory, as HDAC2-overexpressing mice presented
decreased spine density and synaptic plasticity, that corre-
lates with reduced memory formation [56]. These results
confirm the involvement of this histone post-translational
modifier protein in controlling both the adult neurogenic
process and some of the associated cognitive abilities, also
typically affected in stress-related disorders, such as MDD.
Moreover, epigenetic regulators directly involved in
post-mitotic neuronal maturation and differentiation,
have also been associated with several behavioural and
cognitive impairments present in several neuropsychiatric
disorders. Work from Adachi et al. [98], for instance, has
demonstrated that MeCP2 may interfere in neurological
pathways that mediate heightened anxiety. DNMTS,
active epigenetic regulators of adult neurogenesis, partici-
pating throughout all its phases, are also dynamically
involved in blocking memory formation [99,100].
Curiously, DNMT3b, an enzyme responsible for de novo
DNA methylation, has been reported to have an
increased expression in depressive suicide completers.
Interestingly, this increase was significantly more pro-
nounced in women, a result that is in accordance with
the gender preference of MDD (twice more prevalent in
women) [101].
In addition, pharmacological and non-pharmacological
treatments of depression, such as ADs and electroconvul-
sive shock (ECS) therapy, respectively, provide additional
endorsement of the hypothesis that the neurogenic precipi-
tation of depression might be, at least partially, epigeneti-
cally mediated. In fact, imipramine, a tricyclic agent with a
well described pro-neurogenic action [70,79], has beha-
vioural improving actions in a socially defeated mice
model, that correlates with downregulation of HDAC5 in
the hippocampal region [102]. In contrast, viral-mediated
overexpression of HDAC5 counteracts the effects of
chronic imipramine treatment in reversing depressive-like
behaviour. Interestingly, HDAC5 participates in adult neu-
rogenesis regulation, controlling both maturation and sur-
vival of newborn neurons [103]. Interestingly, VPA clinical
effectiveness as a mood stabiliser has been correlated to its
neurogenic enhancement effect [104,105]. Additional stu-
dies showed that VPA, in conjugation with sodium buty-
rate, when administered alone or in combination with the
antidepressant fluoxetine, improves performance in animal
models of behavioural despair [106,107]. Considering that
VPA is also an HDACi, and that HDAC inhibition is
known to drive adult hippocampal neurogenesis [45], these
studies highlight the importance of the pharmacological
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modulation of epigenetic regulators involved in adult neu-
rogenesis to the efficiency of some ADs to ameliorate
depressive behaviour. Non-pharmacological treatment of
MDD, through ECS therapy, is also known to enhance hip-
pocampal neurogenesis [108]. Interestingly, Gadd45b-defi-
cient mice fail to reveal the ECS-induced increase in adult
neurogenesis [62], suggesting that the pro-neurogenic
action of ECS therapy, important for reversing depressive-
like behaviour, might be epigenetically-mediated by
Gadd45b.
Finally, it is worth to mention that this epigenetic regu-
lation is also implicated in the vulnerability to stress,
enhancing the susceptibility to stress-related disorders, in
which depression is included. The role of such epigenetic
mechanisms has recently been highlighted. Indeed,
REST4, a splicing variant of the epigenetic orchestrator
REST, has been shown to have an increased expression
in rats exposed to stress early in life; importantly, these
animals display enhanced susceptibility to stress and
increased susceptibility to depressive-like behaviour
[109]. In addition, KAP1, a crucial component of a
repressive chromatin complex, seems also to be involved
in stress vulnerability. In fact, mice with deletion of
KAP1 in the forebrain exhibit high levels of anxiety-like
behaviour and significant stress-induced impairments in
some cognitive domains, such as attention and spatial
reference memory [110,111]. Therefore, and although
not directly involved on neurogenesis regulation, epige-
netic-mediated increases in the vulnerability to precipita-
tion factors of depression, such as stress, may lead to an
accentuation of the detrimental effects upon the neuro-
genic process dynamics and its regulatory mechanisms,
thus favouring the development of deficits at the beha-
vioural and cognitive levels.
Conclusions - Towards a neuro-epigenetic
hypothesis of depression?
The dynamic and environmentally driven modulation of
neuroplasticity in the adult brain plays a crucial role in
the ethiopathogenesis of depression. As discussed
Figure 3 Role of hippocampal neurogenesis in depression. Hippocampal neuroplasticity is increasingly viewed as central in the
ethiopathogenesis of depression. Chronic exposure to stressors leads to dendritic atrophy on pre-existing granular neurons and compromises
the generation of new neurons during adulthood. Data discussed herein strongly suggests that such impairments in the neurogenic process are
likely attributable to dysfunctions in the epigenetic regulation of neurogenesis, possibly leading to the multidimensional behavioural deficits
associated to depression. Conversely, the question whether the pro-neurogenic action of antidepressants (ADs), which allows to restore normal
cognitive function, may be epigenetically mediated remains also to be elucidated.
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herein, the last two decades provided several lines of
evidence supporting the implication of hippocampal
neurogenesis in the maintenance of the homeostatic
brain function and its importance in the pathophysiol-
ogy of MDD (Figure 4). However, approaches to this
topic have been largely descriptive and the field still
lacks an integrative perspective regarding genes and
molecular determinants influencing neurogenesis in the
installation of such neuropathological conditions;
importantly the same holds true for the positive action
of ADs in this process.
Our comprehension of how adult neurogenesis is regu-
lated begins now to be complemented with new insights
into the complex epigenetic orchestration of this phenom-
enon, a regulatory dimension that is relatively new in neu-
roscience research. Yet, the scattered evidence gathered so
far, opens a new dimension for unravelling the mechanis-
tic explanation for the interplay of genes and environment
Figure 4 Epigenetic regulators of neurogenesis on the development of pathological behavioural traits. Several epigenetic regulators have
been implicated in the control of the adult neurogenic process. As such, it is likely that the mechanistic action of these molecules is implicated in the
behavioural dimensions commonly affected in depression: Mood (M), Anxiety (A) and Cognition (C). “✓” indicates that such involvement has been
described; “?” indicates that the implications of the molecule are unknown or still unclear. a PcG and TrxG protein complexes silence or activate,
respectively, the transcription of target genes and have been implicated in the control of the neurogenic process; however, repercussions at the
behavioural level still remain to be described; b MBD1 action is associated with the histone-lysine N-methyltransferase SETDB1, silencing target genes;
notably, deficits in this molecule has been associated to deficits in all three behavioural dimension of depression. c DNMTs participate in the regulation
of a broad range of neurogenesis processes, being its action strongly related to deficits in learning and memory; although some studies suggest that
they might be also involved in the transcriptional regulation of pathways associated to mood and anxiety, such correlation needs to be further
endorsed; d MeCP2 integrates a major chromatin silencing complex comprising several others epigenetic regulators, such as HDAC1, involved in the
trancriptional regulation of several genes. Deficits in this molecule have been correlated with cognitive and anxiety deficits, although no deficits in
mood have been consistently described; e The REST/CoREST chromatin remodeling complex has been proposed as a major orchestrator of the action
of several epigenetic regulators, such as HDAC 1 and 2, MeCP2 and the histone methyltransferase K4. Impairments in mood an cognition have been
associated with REST and its molecular partners, although no implication have been described relating this molecule to anxiety.
Mateus-Pinheiro et al. Clinical Epigenetics 2011, 3:5
http://www.clinicalepigeneticsjournal.com/content/3/1/5
Page 8 of 12
that is central in several neuropsychiatric pathological sce-
narios. In fact, studies in this area endorse the role of epi-
genetic mechanisms as transducers of the environmental
signals into transcriptional outcomes, strongly suggesting
that they may participate in the precipitation of experi-
ence-dependent psychiatric disorders, like depression, and
simultaneously mediate the pro-neurogenic action of com-
monly prescribed ADs. Therefore, epigenetic mechanisms
begin to emerge as mediators through which environment
modulates neurogenesis with long-lasting and stable reper-
cussions in several behavioural and cognitive domains
(Figure 5). In this perspective, it becomes plausible that by
reverting the pathological effects on epigenetic key regula-
tors, one can counteract the deleterious effects of stress
and other precipitators of depression, thus restoring nor-
mal neurogenic function. Hence, future research focused
on dissecting the epigenetic pathways that modulate the
adult neurogenesis process will be decisive to further unra-
vel the neurobiological basis of depression and may pave
the way to the development of novel therapies and to the
discovery of new therapeutical targets in this pathological
context.
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